Philips and Medtronic advocacy partnership aims to help accelerate access to life-saving treatments
24 Ottobre 2024 - 3:00PM
UK Regulatory
Philips and Medtronic advocacy partnership aims to help accelerate
access to life-saving treatments
October 24, 2024
Both companies also join the newly established World Stroke
Organization Advocacy Coalition
Amsterdam, the Netherlands – Royal Philips
(NYSE: PHG, AEX: PHIA), a global leader in health technology, and
Medtronic Neurovascular, a leading innovator in neurovascular
therapies, today announced a strategic advocacy partnership.
Delivering timely stroke care is crucial to saving lives and
reducing long-term disability. As leaders in stroke diagnosis and
treatment, the two organizations are advocating on raising
awareness around the potential health and economic benefits for
patients, their families and societies of improving access to
timely stroke diagnosis and treatment.
Philips and Medtronic Neurovascular also further expanded and
strengthened their partnerships with the World Stroke Organization
(WSO) by joining the newly established WSO Advocacy Coalition. This
WSO-led coalition brings together diverse stakeholders, including
healthcare professionals, patient groups, and policymakers, to
develop coordinated strategies that address the global burden of
stroke. The two companies are already working together with the
World Stroke Organization to share the latest research, exchange
best practices, drive improvements and advance the stroke policy
agenda.
A stroke is typically an acute event, mostly caused by a
blockage in a blood vessel in the brain that prevents adequate
blood supply to brain tissue and leads to permanent loss of brain
cells. It is a leading cause of disability and death worldwide,
affecting an estimated 12 million people globally every year,
including an increasing number of young people. The direct and
indirect costs are conservatively estimated to be around USD 900
billion annually and are expected to almost double over the next 25
years.
Philips and Medtronic Neurovascular are advocating for a global
network of stroke care centers that can deliver comprehensive care,
from early diagnosis to rehabilitation. Their joint efforts focus
on three key areas:
- Raising awareness: Promoting public
understanding of stroke symptoms and the importance of seeking
immediate care.
- Improving access to treatment: Expanding the
number of stroke-ready hospitals and providing training to
healthcare professionals on the latest interventional
techniques.
- Leveraging technology and innovation:
Utilizing advanced imaging and digital health tools to create
integrated stroke care systems that support early diagnosis,
effective treatment, and post-procedure monitoring.
The collaboration will be highlighted at the upcoming World
Stroke Congress (October 23-26) in Abu Dhabi, where Philips and
Medtronic Neurovascular will host a Stroke Advocacy roundtable
session. This initiative builds on their joint presence at events
such as the United Nations General Assembly and the World Health
Assembly, where they emphasized the need for increased investments
in stroke care infrastructure and supportive policy changes.
“Our new partnership with Medtronic Neurovascular and the
ongoing collaboration with the World Stroke Organization highlights
our shared commitment to transforming stroke care. With advanced
technologies and a focus on collaboration, the time to act is now
to ensure that stroke patients have timely stroke care — no matter
where they live,” said Carla Goulart Peron, Chief Medical Officer,
Philips.
“Stroke care is a race against time, and by joining forces with
Philips, we can help accelerate access to life-saving treatments
like mechanical thrombectomy. Together, we are advocating for
necessary investments in stroke care infrastructure to reduce the
burden on patients and healthcare systems globally,” said Signe
Haughton, Chief of Staff, Senior Director of Medical &
Government Affairs, Medtronic Neurovascular.
WSO Advocacy Coalition
Philips’ partnership with the World Stroke Organization,
established in 2023, has now been further expanded and strengthened
by Philips’ involvement in the WSO Advocacy Coalition. While the
initial partnership focused on improving access to high-quality
stroke care globally, this new collaboration deepens Philips' role
in global stroke advocacy. By joining the WSO Advocacy Coalition,
Philips is now part of a global network that actively works on
healthcare policy, raise public awareness, and advocate for
increased investment in stroke care infrastructure.
[1] World Stroke Organization - Time for a Revolution in Stroke
Care
[2] The Lancet Neurology - Pragmatic solutions to reduce the global
burden of stroke
For further information, please contact:
Joost Maltha
Philips External Relations
Tel. : +31 6 10558116
E-mail : joost.maltha@philips.com
Kelli Lynch
Medtronic Public Relations
Tel.: + 1 203-500-3328
E-mail: Kelli.b.lynch@medtronic.com
About Royal Philips
Royal
Philips (NYSE: PHG, AEX: PHIA) is a leading health technology
company focused on improving people's health and well-being through
meaningful innovation. Philips’ patient- and people-centric
innovation leverages advanced technology and deep clinical and
consumer insights to deliver personal health solutions for
consumers and professional health solutions for healthcare
providers and their patients in the hospital and the home.
Headquartered in the Netherlands, the company is a leader in
diagnostic imaging, ultrasound, image-guided therapy, monitoring,
and enterprise informatics, as well as in personal health. Philips
generated 2023 sales of EUR 18.2 billion and employs approximately
69,700 employees with sales and services in more than 100
countries. News about Philips can be found at
www.philips.com/newscenter.
About Medtronic
Bold thinking. Bolder
actions. We are Medtronic. Medtronic plc, headquartered in Galway,
Ireland, is the leading global healthcare technology company that
boldly attacks the most challenging health problems facing humanity
by searching out and finding solutions. Our Mission — to alleviate
pain, restore health, and extend life — unites a global team of
95,000+ passionate people across more than 150 countries. Our
technologies and therapies treat 70 health conditions and include
cardiac devices, surgical robotics, insulin pumps, surgical tools,
patient monitoring systems, and more. Powered by our diverse
knowledge, insatiable curiosity, and desire to help all those who
need it, we deliver innovative technologies that transform the
lives of two people every second, every hour, every day. Expect
more from us as we empower insight-driven care, experiences that
put people first, and better outcomes for our world. In everything
we do, we are engineering the extraordinary. For more information
on Medtronic, visit www.Medtronic.com and follow on LinkedIn.
Any forward-looking statements are subject to risks and
uncertainties such as those described in Medtronic's periodic
reports on file with the Securities and Exchange Commission. Actual
results may differ materially from anticipated results.
- Stroke patient
- Stroke patient recovering
- Philips stroke Azurion interventional suite
Grafico Azioni Koninklijke Philips NV (EU:PHIA)
Storico
Da Nov 2024 a Dic 2024
Grafico Azioni Koninklijke Philips NV (EU:PHIA)
Storico
Da Dic 2023 a Dic 2024